Nottingham, United Kingdom

Moein Moghimi


Average Co-Inventor Count = 4.0

ph-index = 2

Forward Citations = 26(Granted Patents)


Company Filing History:


Years Active: 1998-1999

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Moein Moghimi

Introduction

Moein Moghimi is a notable inventor based in Nottingham, GB. He has made significant contributions to the field of drug delivery systems, particularly focusing on lymphatic delivery methods. With a total of 2 patents to his name, Moghimi's work is paving the way for advancements in medical treatments.

Latest Patents

Moghimi's latest patents include innovative compositions for delivering active agents to the lymphatic system. One of his notable inventions involves a composition that comprises a plurality of colloidal particles, each associated with an active agent. The surface of these particles is designed to have a hydrophobicity ratio of less than 10. Additionally, a modifying agent can be adsorbed onto the surface of each particle, which results in an advancing contact angle of less than 60 degrees. The adsorbed layer thickness is defined to be less than 10 nm, and the albumin uptake ratio is maintained between 0.2 and 0.5. These compositions may satisfy one or more of these specific requirements, with preferred modifying agents being non-ionic surfactants, particularly block copolymers containing polyethylene glycol.

Career Highlights

Moein Moghimi is currently associated with Danbiosyst UK Limited, where he continues to innovate in the field of drug delivery. His work is characterized by a commitment to improving the efficacy of treatments through advanced delivery methods.

Collaborations

Moghimi has collaborated with esteemed colleagues such as Stanley Stewart Davis and Lisbeth Illum, contributing to a dynamic research environment that fosters innovation.

Conclusion

Moein Moghimi's contributions to lymphatic delivery methods represent a significant advancement in medical technology. His innovative patents and collaborations highlight his dedication to improving healthcare solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…